$1.60 +0.02 (1.27%) Cormedix Inc - NYSE Amex Equities

Aug. 26, 2016 | 03:59 PM
Last Trade: 1.60
Trade Time: Aug 26 03:59 PM Eastern Daylight Time
Change: +0.02 (1.27%)
Prev Close: 1.58
Open: 1.58
Bid: 1.57
Ask: 1.64
  1. No results found.
  1. Benzinga's Top Initiations

    Benzinga | Nov. 12, 2015 | 10:08AM EST
  2. Pacific Premier Bancorp, Inc. Announces the Appointment of New Director

    Benzinga | Oct. 7, 2015 | 06:00AM EST
  3. Exclusive: Elliott's Paul Singer Says Rumors Of Yahoo Position Are Not True

    Benzinga | Aug. 13, 2015 | 16:16PM EST
  4. SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in ...

    GuruFocus | Aug. 8, 2015 | 00:03AM EST
  5. Market Update: Monday's Mid-Day Movers; Greece Opens Banks; Gold Dwindles

    Benzinga | Jul. 20, 2015 | 12:03PM EST
  6. Morning Market Losers

    Benzinga | Jul. 20, 2015 | 09:53AM EST
  7. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CorMedix, Inc. ...

    GuruFocus | Jul. 17, 2015 | 00:03AM EST
  8. Morning Market Gainers

    Benzinga | Jun. 17, 2015 | 09:42AM EST
  9. Paul Singer Adds to Six Stakes in First Quarter

    GuruFocus | May. 21, 2015 | 19:02PM EST
  10. CorMedix Receives Approval From FDA to Initiate a Clinical Trial for Neutrolin in the US

    GuruFocus | Oct. 27, 2014 | 12:05PM EST
  11. Morning Market Movers

    Benzinga | Oct. 27, 2014 | 09:55AM EST
  12. Morning Market Movers

    Benzinga | Jun. 24, 2014 | 09:40AM EST
  13. CorMedix Welcomes Additional Board Members

    Benzinga | Apr. 7, 2014 | 08:33AM EST
  14. CorMedix to Raise $2,M in Offering

    Benzinga | Jan. 8, 2014 | 09:23AM EST
  15. CorMedix Receives Minutes from Neutrolin Pre-IND Meeting with FDA

    Benzinga | Dec. 23, 2013 | 09:53AM EST
Trading Center